including nasal polyps is a chronic inflammatory disease involving the mucosa of the nose and one or more paranasal sinuses. Despite differing hypotheses, the cause remains poorly understood.

China approves GSK's Nucala for chronic rhinosinusitis with nasal polyps, adding to its existing uses in asthma and other ...

Dazostinag sodium is under clinical development by Takeda Pharmaceutical and currently in Phase II for Paranasal Sinus And Nasal Cavity Cancer.

Nasal polyps are fleshy swellings that develop in the lining of the nose and paranasal sinuses, which are the ... most commonly develop in those with chronic rhinosinusitis, which has resulted ...

This technique advocates a systematic approach to treating diseases of the nose and paranasal sinuses. There has been an overwhelming positive response among practicing clinicians to learn FESS ...

Nasal polyps can be a persistent issue for individuals suffering from chronic ... term sinus health management. What is Nasal Polyp Surgery? Nasal polyp surgery removes polyps from the paranasal ...

Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Paranasal Sinus And Nasal Cavity Cancer.

It is estimated that about 107 million people in China suffer from chronic sinusitis, about 1/3 of ... Nucala for chronic obstructive pulmonary disease or smoker's lungs. The trial met its primary ...